+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Sleep Aids Market by Product, Sleep-Disorder, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011774
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Sleep Aids Market grew from USD 59.32 billion in 2023 to USD 64.15 billion in 2024. It is expected to continue growing at a CAGR of 5.98%, reaching USD 89.11 billion by 2030.

The sleep aids market encompasses a range of products designed to improve sleep quality, including prescription drugs, over-the-counter medications, herbal supplements, and devices like sleep masks or white noise machines. These aids are increasingly necessary due to rising cases of sleep disorders such as insomnia and sleep apnea, driven by modern lifestyle stress, growing digitalization, and a global surge in mental health issues. The application extends across diverse age groups, though it's particularly pertinent among the elderly who often face chronic sleep issues, and younger populations affected by irregular work hours and stress. End-use sectors include pharmacies, online vendors, and health institutions where these products are prominently utilized. Key growth factors include heightened consumer health awareness, increasing disposable incomes, and advancements in medical research providing new product innovations. Opportunities lie in personalized sleep solutions and tech-integrated products like smart sleep devices and apps, which are becoming popular due to their ability to track and enhance sleep patterns. The trend towards natural and herbal sleep solutions also presents lucrative potential. However, challenges persist in terms of product side effects, stringent regulatory requirements for drug approvals, and consumer skepticism towards chemical-based sleep aids. To overcome these, companies should focus on research and innovation in plant-based and non-pharmacological solutions, as well as collaborate with digital health startups to explore data-driven sleep improvement solutions. Additionally, expanding in emerging economies with increasing healthcare spending and improving sleep disorder awareness could drive growth. The market is dynamic and competitive, necessitating a strong grasp of changing consumer preferences and regulatory landscapes. Emphasizing sustainable and ethically produced solutions will also cater to environmentally-conscious consumers, marking a critical area for future growth and innovation.

Understanding Market Dynamics in the Sleep Aids Market

The Sleep Aids Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing need for treating & diagnosing different forms of sleep conditions
    • Rising public awareness of the sleep disorders
    • Growing acceptance of wearable sensors and tracking devices
  • Market Restraints
    • Inappropriate calibration of devices of sleeping aids
  • Market Opportunities
    • Introduction of novel technologies in sleeping aids
    • Growing government funding for research & development (R&D) to bid huge sleep aids
  • Market Challenges
    • Absence of appropriate documents for the permitting license

Exploring Porter’s Five Forces for the Sleep Aids Market

Porter’s Five Forces framework further strengthens the insights of the Sleep Aids Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Sleep Aids Market

External macro-environmental factors deeply influence the performance of the Sleep Aids Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Sleep Aids Market

The Sleep Aids Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Sleep Aids Market

The Sleep Aids Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Sleep Aids Market

The Sleep Aids Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sleep Aids Market, highlighting leading vendors and their innovative profiles. These include Apnea Sciences Corporation, Boehringer Ingelheim International GmbH, Cadwell Industries Inc., Cleveland Medical Devices Inc., Compumedics Limited, Drive DeVilbiss Healthcare Inc., Eisai Co., Ltd., Fisher & Paykel Healthcare Corp. Ltd., Koninklijke Philips N. V., Merck and Co. Inc., Natus Medical Inc., Nihon Kohden Corporation, Pfizer Inc., ResMed Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Sleep Aids Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Mattresses & Pillows
    • Medications
      • Herbal Drugs
      • OTC Drugs
      • Prescription-Based Drugs
    • Sleep Apnea Devices
      • Adaptive Servo-Ventilators (ASVs)
      • Facial Interfaces
      • Oral Appliances
      • Positive Airway Pressure (PAP) Devices
  • Sleep-Disorder
    • Insomnia
    • Narcolepsy
    • Restless Legs Syndrome
    • Sleep Apnea
    • Sleep Walking
  • Distribution Channel
    • Drug Stores
    • E-Commerce
    • Hospital Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing need for treating & diagnosing different forms of sleep conditions
5.1.1.2. Rising public awareness of the sleep disorders
5.1.1.3. Growing acceptance of wearable sensors and tracking devices
5.1.2. Restraints
5.1.2.1. Inappropriate calibration of devices of sleeping aids
5.1.3. Opportunities
5.1.3.1. Introduction of novel technologies in sleeping aids
5.1.3.2. Growing government funding for research & development (R&D) to bid huge sleep aids
5.1.4. Challenges
5.1.4.1. Absence of appropriate documents for the permitting license
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Sleep Aids Market, by Product
6.1. Introduction
6.2. Mattresses & Pillows
6.3. Medications
6.3.1. Herbal Drugs
6.3.2. OTC Drugs
6.3.3. Prescription-Based Drugs
6.4. Sleep Apnea Devices
6.4.1. Adaptive Servo-Ventilators (ASVs)
6.4.2. Facial Interfaces
6.4.3. Oral Appliances
6.4.4. Positive Airway Pressure (PAP) Devices
7. Sleep Aids Market, by Sleep-Disorder
7.1. Introduction
7.2. Insomnia
7.3. Narcolepsy
7.4. Restless Legs Syndrome
7.5. Sleep Apnea
7.6. Sleep Walking
8. Sleep Aids Market, by Distribution Channel
8.1. Introduction
8.2. Drug Stores
8.3. E-Commerce
8.4. Hospital Pharmacies
8.5. Retail Pharmacies
9. Americas Sleep Aids Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Sleep Aids Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Sleep Aids Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. SLEEP AIDS MARKET RESEARCH PROCESS
FIGURE 2. SLEEP AIDS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SLEEP AIDS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SLEEP AIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. SLEEP AIDS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. SLEEP AIDS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. SLEEP AIDS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SLEEP AIDS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SLEEP AIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SLEEP AIDS MARKET DYNAMICS
TABLE 7. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SLEEP AIDS MARKET SIZE, BY MATTRESSES & PILLOWS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SLEEP AIDS MARKET SIZE, BY HERBAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SLEEP AIDS MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SLEEP AIDS MARKET SIZE, BY PRESCRIPTION-BASED DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SLEEP AIDS MARKET SIZE, BY ADAPTIVE SERVO-VENTILATORS (ASVS), BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SLEEP AIDS MARKET SIZE, BY FACIAL INTERFACES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SLEEP AIDS MARKET SIZE, BY ORAL APPLIANCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SLEEP AIDS MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SLEEP AIDS MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SLEEP AIDS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SLEEP AIDS MARKET SIZE, BY RESTLESS LEGS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP WALKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SLEEP AIDS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SLEEP AIDS MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SLEEP AIDS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SLEEP AIDS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. CANADA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CANADA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 49. CANADA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 50. CANADA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 51. CANADA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. MEXICO SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. MEXICO SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 54. MEXICO SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 55. MEXICO SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 56. MEXICO SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. CHINA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. CHINA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 76. CHINA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 77. CHINA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 78. CHINA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. INDIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. INDIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 81. INDIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 82. INDIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 83. INDIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. JAPAN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. JAPAN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 91. JAPAN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 92. JAPAN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 93. JAPAN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. THAILAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. THAILAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 121. THAILAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 122. THAILAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 123. THAILAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. DENMARK SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 137. DENMARK SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 138. DENMARK SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 139. DENMARK SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. EGYPT SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. EGYPT SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 142. EGYPT SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 143. EGYPT SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 144. EGYPT SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. FINLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. FINLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 147. FINLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 148. FINLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 149. FINLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. FRANCE SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. FRANCE SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 152. FRANCE SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 153. FRANCE SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 154. FRANCE SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. GERMANY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. GERMANY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 158. GERMANY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 159. GERMANY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. ITALY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. ITALY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 167. ITALY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 168. ITALY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 169. ITALY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. NORWAY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. NORWAY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 182. NORWAY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 183. NORWAY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 184. NORWAY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. POLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. POLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 187. POLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 188. POLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 189. POLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. QATAR SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. QATAR SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 192. QATAR SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 193. QATAR SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 194. QATAR SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. SPAIN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. SPAIN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 212. SPAIN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 213. SPAIN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 214. SPAIN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. TURKEY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. TURKEY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 228. TURKEY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 229. TURKEY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. SLEEP AIDS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 241. SLEEP AIDS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Sleep Aids market, which are profiled in this report, include:
  • Apnea Sciences Corporation
  • Boehringer Ingelheim International GmbH
  • Cadwell Industries Inc.
  • Cleveland Medical Devices Inc.
  • Compumedics Limited
  • Drive DeVilbiss Healthcare Inc.
  • Eisai Co., Ltd.
  • Fisher & Paykel Healthcare Corp. Ltd.
  • Koninklijke Philips N. V.
  • Merck and Co. Inc.
  • Natus Medical Inc.
  • Nihon Kohden Corporation
  • Pfizer Inc.
  • ResMed Inc.
  • Sanofi S.A.

Methodology

Loading
LOADING...

Table Information